Madappa Kundranda, MD, PhD, discusses the sequencing of second-line therapies in hepatocellular carcinoma.
Madappa Kundranda, MD,PhD
Advertisement
Articles by Madappa Kundranda, MD,PhD
Madappa Kundranda, MD, PhD, discusses the need to develop novel treatments in pancreatic ductal adenocarcinoma.
Advertisement
Latest Updated Articles
Dr. Kundranda on the Sequencing of Second-Line Therapies in HCCPublished: February 9th 2023 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
4
Dr Spencer on First-Line Chemo Selection in Metastatic Pancreatic Adenocarcinoma
5